ING/WellPoint and Aetna may or may not be talking, but several Aetna shareholders definitely want them to. Following Aetna’s rejection of their bid, which analysts valued at close to $70 a share, Aetna announced that it intended to split into two companies. Its shares have since fallen to the low $50s, which is at least better that its eight-year low of $38.50 a share reached in February. The complaining shareholders thought the takeover rejection was an error and have filed suit against Aetna in a Connecticut Superior Court alleging that it refused to adequately consider the ING/WellPoint bid simply to protect current management.
Topics Lawsuits
Was this article valuable?
Here are more articles you may enjoy.
‘Structural Shift’ Occurring in California Surplus Lines 
State Farm Adjuster’s Opinion Does Not Override Policy Exclusion in MS Sewage Backup 
Trump’s EPA Rollbacks Will Reverberate for ‘Decades’ 
CFC Owners Said to Tap Banks for Sale, IPO of £5 Billion Insurer From This Issue
